Cardioprotective effect of Chinese herbal medicine for anthracycline-induced cardiotoxicity in cancer patients: A meta-analysis of prospective studies-Reference-Cited by-同舟云学术

Cardioprotective effect of Chinese herbal medicine for anthracycline-induced cardiotoxicity in cancer patients: A meta-analysis of prospective studies

Published:2022-07-29 Issue:30 Volume:101 Page:e29691
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Hao Wei,Shi You-Yang,Qin Yue-Nong,Sun Chen-Ping,Chen Li-Ying,Wu Chun-Yu,Bao Yi-Jia,Liu Sheng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference44 articles.

1. Anthracycline-induced cardiotoxicity: causes, mechanisms, and prevention.;Bhagat;Adv Exp Med Biol,2020

2. Correction to: statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis.;Obasi;Cancer Causes Control,2021

3. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.;Tan;Cancer,1967

4. Chemotherapy-associated cardiomyopathy: mechanisms of toxicity and cardioprotective strategies.;Veeder;Pharmacotherapy,2021

5. Mechanisms of anthracycline-enhanced reactive oxygen metabolism in tumor cells.;Doroshow;Oxid Med Cell Longev,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-oncology: Examination of progress in China from an oncologist's perspective;Asia-Pacific Journal of Oncology Nursing;2024-06

2. Synergistic and Additive Effects of Herbal Medicines in Combination with Chemotherapeutics: A Scoping Review;Integrative Cancer Therapies;2024-01

3. The Role of Epithelial Mesenchymal Transition (EMT) in Pathogenesis of Cardiotoxicity: Diagnostic & Prognostic Approach;Molecular Biotechnology;2023-02-27

4. Advancing Cardio-Oncology in Asia;Korean Circulation Journal;2023

5. Managing Long-Term Health Risks for Breast Cancer Survivors;Integrative Oncology in Breast Cancer Care;2023